Site Members can sign up for company wide alerts
Lawsuit Overview
October 21, 2014 (Shareholders Foundation) - An investor, who currently holds shares of Durata Therapeutics Inc (NASDAQ:DRTX), filed a lawsuit in effort to halt the proposed takeover of Durata Therapeutics Inc by Actavis plc for $23 per share. The plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ:DRTX stockholders by agreeing to sell Durata Therapeu...
You must register (for free) or login to view the entire case.